ChartRow logo
Data provided bySource: Twelve Data
PeersBDXRMDALCSOLVRGENBAX
Share this page

WST — West Pharmaceutical Services Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in WST be worth today? →
WST returns: By year · By month · By week · Trailing

Price data

Price
$399.81
YTD price return
+45.31%
YTD total return
+45.65%
Market cap
27.9B
Enterprise value
27.7B
Shares outstanding
69.7M
52W low
$223.83
52W high
$438.27
From 52W high
-8.78%
From 52W low
+78.62%
52W range
82%$224–$438
Beta
1.13

Volume

Rel volume
0.91×
30D volume
683.2K
30D $ vol
267.7M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$5.4M
Insider net 1Y
−$6.6M

Form 4 transactions by trade date, as filed; latest on file 2026-09-15.

Fundamentals

Sales (ttm)
3.4B
Sales/share
$48.76
EPS (ttm)
$8.90
FCF (ttm)
453.4M
FCF/share
$6.51
Book value/share
$42.61
Net margin
18.81%
ROE
21.52%
ROA
15.73%
Debt / equity
0.07×
Current ratio
2.82

Growth (CAGR, ttm) · 10Y

Sales
+12.56%+5.09%+4.85%+8.62%
Net income
+29.96%+4.53%+0.85%+16.58%
FCF
+19.61%+2.58%+6.10%+25.15%
Shares
-3.17%-1.99%-1.22%-0.49%

Per-share growth (CAGR, ttm) · 10Y

EPS
+31.91%+6.28%+2.00%+17.02%
Sales/share
+16.25%+7.22%+6.14%+9.15%
FCF/share
+23.54%+4.66%+7.41%+25.77%
Book value/share
+0.46%+3.20%+7.47%+10.57%
Dividend/share
+6.85%+5.81%+5.79%+6.29%
Price
+45.24%+6.28%-0.20%+18.15%
Total return
+45.70%+6.58%+0.07%+18.56%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
44.9×
P/OI (ttm)
35.7×
Fwd P/E
39.3×
P/S (ttm)
8.2×
P/B (mrq)
9.4×
P/FCF (ttm)
61.4×
EV/EBITDA (fy)
28.7×
EV/Sales (ttm)
8.2×
FCF yield (ttm)
1.63%
Dividend yield (fwd)Div yield
0.22%
Dividend yield (ttm)
0.22%
Dividend/share (fwd)
$0.88
Buyback yield (realized, 1y)
3.17%
Shareholder yield (realized, 1y)
3.51%
Buyback yield (cash, ttm)
2.46%
Shareholder yield (cash, ttm)
2.69%

Vs own 10Y history

P/E
48th
P/OI
47th
P/S
66th
P/B
70th
P/FCF
53rd

Bar = where today’s multiple sits in WST’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
+1.87%
5D
-3.10%
1M
+7.29%
3M
+14.69%
YTD
+45.31%
1Y
+45.21%
5Y
-0.98%
1D
+1.87%
5D
-3.10%
1M
+7.29%
3M
+14.69%
YTD
+45.65%
1Y
+45.66%
5Y
+0.33%

Fundamentals#

Revenue

5Y CAGR +7.4%10Y CAGR +8.2%YoY +8.7%
$3.4B TTM$874.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +7.5%10Y CAGR +16.4%YoY +59.5%
$780.2M TTM$267.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +8.2%10Y CAGR +18.0%YoY +57.3%
$8.90 TTM$3.02 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +9.5%10Y CAGR +19.2%YoY +12.3%
$453.4M TTM$150.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $654.5M, capex −$201.1M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $189.5M, capex −$39.1M

Shares (diluted)

5Y −4.1%10Y −1.5%YoY −2.5%
71.8M TTM70.8M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +5.4%10Y CAGR +6.5%YoY +0.0%
$0.90 TTM$0.22 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full WST financials →

About West Pharmaceutical Services#

Data provided bySource: Twelve Data

West Pharmaceutical Services Inc. is a healthcare products manufacturer focused on the design, development, and production of containment and delivery systems for injectable drugs and other healthcare products. The company supplies critical components such as stoppers, seals, syringe and cartridge parts, reconstitution and transfer systems, safety and administration devices, and advanced injection solutions that support the packaging and delivery of pharmaceuticals and biologics. It also provides contract manufacturing and analytical lab services through its proprietary and contract-manufactured product segments. West Pharmaceutical Services Inc. serves a broad customer base that includes pharmaceutical, biotechnology, generic-drug, medical device, and consumer healthcare companies. Headquartered in Exton, Pennsylvania, the company plays an important role in the healthcare supply chain by helping enable safe, reliable, and efficient delivery of injectable therapies worldwide.

Exton, PA·10,800 employees·Medical Instruments & Supplies·westpharma.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding WST#

35 of the 193 ETFs ChartRow carries live hold WST. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
NOBLProShares S&P 500 Dividend Aristocrats ETF1.3%
VOTVanguard Mid-Cap Growth ETF0.6%
XLVHealth Care Select Sector SPDR Fund0.4%
VHTVanguard Health Care ETF0.3%
IWSiShares Russell Mid-Cap Value ETF0.2%
VOVanguard Mid-Cap ETF0.2%
RSPInvesco S&P 500 Equal Weight ETF0.2%
IWRiShares Russell Midcap ETF0.2%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%